EGFR and cancer: The incubation of cancer cells for more than two hours with FQTT derivatives leads to the significant degradation of the EGFR, which is accompanied by a decrease in the content of cytoskeletal proteins β-actin and α-tubulin, commonly used as load controls in Western blotting.